Lanzhou Foci Pharmaceutical Co (SZSE:002644) Total Liabilities : ¥585.7 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co Total Liabilities?

Lanzhou Foci Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥585.7 Mil.

Lanzhou Foci Pharmaceutical Co's quarterly Total Liabilities declined from Sep. 2024 (¥677.62 Mil) to Dec. 2024 (¥654.81 Mil) and declined from Dec. 2024 (¥654.81 Mil) to Mar. 2025 (¥585.67 Mil).

Lanzhou Foci Pharmaceutical Co's annual Total Liabilities declined from Dec. 2022 (¥865.21 Mil) to Dec. 2023 (¥759.67 Mil) and declined from Dec. 2023 (¥759.67 Mil) to Dec. 2024 (¥654.81 Mil).

Lanzhou Foci Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Lanzhou Foci Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanzhou Foci Pharmaceutical Co Total Liabilities Chart

Lanzhou Foci Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

800.08

724.59

865.21

759.67

654.81

Lanzhou Foci Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															740.43	693.75	677.62	654.81	585.67

Lanzhou Foci Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lanzhou Foci Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	379.729	+	(2.849	+	259.028
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	13.2)
	=	654.8

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	2469.785	-	1814.979
	=	654.8

Lanzhou Foci Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	324.788	+	(5.026	+	255.852
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	13.2)
	=	585.7

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	2420.771	-	1835.106
	=	585.7

Lanzhou Foci Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Lanzhou Foci Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lanzhou Foci Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046

Website

http://www.fczy.com

Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australia, Russia, and Ukraine, among others.

Executives

Sun Yu	Directors, executives
Su Wen Bo	Supervisors
An Wen Ting	Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines